Background. Acne vulgaris is a common skin disease that can adversely affect the quality of life of patients. Objective. The aim of this study was to determine the quality of life in patients with acne vulgaris. Methods. This study was carried out on 70 patients with acne vulgaris (28 males, 42 females). All the patients filled out two Persian versions of questionnaires: short form 36 (SF-36) and Dermatology Life Quality Index (DLQI). The obtained data were analyzed by using SPSS software (version 17). Results. The scores for physical functioning, social functioning, and bodily pain domains in patients were over 70%, but the scores for role physical, general health, vitality, role emotional, and mental health in patients were under 70%. Scores on the DLQI in patients with acne vulgaris ranged from 0 to 22 (mean ± SD, 8.18 ± 4.83). After comparing mean score of DLQI with respect to gender and age, it was found that the difference between the two groups was not statistically significant. Conclusion. Acne vulgaris has a significant effect on the quality of life. There was not any significant gender or age related difference in QOL. 1. Introduction Quality of life is a general term which includes a feeling of joy and satisfaction with life. Quality of life (QOL), self confidences, and self esteem in patients with skin diseases have not sufficiently been attended to. Since skin diseases affect well-being, general health, function, and social adaptation of the individual, they can decrease self confidence of the patient and definitely disrupt self image or cutaneous body image, mental health, and quality of his life [1, 2]. By even having chronic itching, life of a person will be charily disturbed [3]. Besides evaluating the treating procedure, recording QOL can advance our knowledge regarding psychosocial stress associated with dermatologic disorders [4]. According to the studies carried out in Canada [5], USA [6], Egypt [7], Denmark [8], Iran [9], UK [10], Turkey [11], Saudi Arabia [12], Brazil [13], and many other countries [14–19], skin diseases have a great effect on the QOL of patients. Patient’s life would be influenced by acne vulgaris both physically and emotionally [15]. Psychological involvements include anxiety, depression, and those which deeply affect life’s quality [16, 17]. The present study can declare the importance of psychological aspects to its readers to the extent that psychological consultation and intervention may be in regard to patients with acne vulgaris. Moreover, measuring the incapacities of patients with the aim of taking
References
[1]
A. Potocka, K. Turczyn-Jablo？ska, and D. Merecz, “Psychological correlates of quality of life in dermatology patients: the role of mental health and self-acceptance,” Acta Dermatovenerologica Alpina, Pannonica et Adriatica, vol. 18, no. 2, pp. 53–62, 2009.
[2]
Y. Higaki, I. Watanabe, T. Masaki et al., “Japanese version of cutaneous body image scale: translation and validation,” Journal of Dermatology, vol. 36, no. 9, pp. 477–484, 2009.
[3]
L. Misery, A. Y. Finlay, N. Martin et al., “Atopic dermatitis: impact on the quality of life of patients and their partners,” Dermatology, vol. 215, no. 2, pp. 123–129, 2007.
[4]
A. K. Wahl, C. M？rk, B. M？rk Lillehol et al., “Changes in quality of life in persons with eczema and psoriasis after treatment in Departments of Dermatology,” Acta Dermato-Venereologica, vol. 86, no. 3, pp. 198–201, 2006.
[5]
J. K. L. Tan, Y. Li, K. Fung et al., “Divergence of demographic factors associated with clinical severity compared with quality of life impact in acne,” Journal of Cutaneous Medicine and Surgery, vol. 12, no. 5, pp. 235–242, 2008.
[6]
A. Taylor, M. Pawaskar, S. L. Taylor, R. Balkrishnan, and S. R. Feldman, “Prevalence of pigmentary disorders and their impact on quality of life: a prospective cohort study,” Journal of Cosmetic Dermatology, vol. 7, no. 3, pp. 164–168, 2008.
[7]
K. Abdel-Hafez, A. M. Mahran, E. R. M. Hofny, K. A. Mohammed, A. M. Darweesh, and A. A. Aal, “The impact of acne vulgaris on the quality of life and psychologic status in patients from upper Egypt,” International Journal of Dermatology, vol. 48, no. 3, pp. 280–285, 2009.
[8]
R. S. Cvetkovski, R. Zachariae, H. Jensen, J. Olsen, J. D. Johansen, and T. Agner, “Quality of life and depression in a population of occupational hand eczema patients,” Contact Dermatitis, vol. 54, no. 2, pp. 106–111, 2006.
[9]
S. Aghaei, M. Sodaifi, P. Jafari, N. Mazharinia, and A. Y. Finlay, “DLQ1 scores in vitiligo: reliability and validity of the Persian version,” BMC Dermatology, vol. 4, article 8, 2004.
[10]
M. K. A. Basra, R. Fenech, R. M. Gatt, M. S. Salek, and A. Y. Finlay, “The Dermatology Life Quality Index 1994–2007: a comprehensive review of validation data and clinical results,” British Journal of Dermatology, vol. 159, no. 5, pp. 997–1035, 2008.
[11]
S. ？ztürkcan, A. T. Ermertcan, E. Eser, and M. Turhan ？ahin, “Cross validation of the Turkish version of dermatology life quality index,” International Journal of Dermatology, vol. 45, no. 11, pp. 1300–1307, 2006.
[12]
A. A. Al Robaee, “Assessment of general health and quality of life inpatients with acne using a validated generic questionnaire,” Acta Dermatovenerologica Alpina, Pannonica et Adriatica, vol. 18, no. 4, pp. 157–164, 2009.
[13]
M. W. B. Ludwig, M. D. S. Oliveira, M. C. Muller, and J. F. D. De Moraes, “Quality of life and site of the lesion in dermatological patients,” Anais Brasileiros de Dermatologia, vol. 84, no. 2, pp. 143–150, 2009.
[14]
A. Y. Finlay and G. K. Khan, “Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use,” Clinical and Experimental Dermatology, vol. 19, no. 3, pp. 210–216, 1994.
[15]
E. Uhlenhake, B. A. Yentzer, and S. R. Feldman, “Acne vulgaris and depression: a retrospective examination,” Journal of Cosmetic Dermatology, vol. 9, no. 1, pp. 59–63, 2010.
[16]
Y. Kaymak, E. Taner, and Y. Taner, “Comparison of depression, anxiety and life quality in acne vulgaris patients who were treated with either isotretinoin or topical agents,” International Journal of Dermatology, vol. 48, no. 1, pp. 41–46, 2009.
[17]
V. Niemeier, J. Kupfer, and U. Gieler, “Acne vulgaris—psychosomatic aspects,” Journal of the German Society of Dermatology, vol. 4, no. 12, pp. 1027–1036, 2006.
[18]
M. Kobayashi, K. Kabashima, M. Nakamura, and Y. Tokura, “Effects of oral antibiotic roxithromycin on quality of life in acne patients,” Journal of Dermatology, vol. 36, no. 7, pp. 383–391, 2009.
[19]
S. Caruso, S. Rugolo, C. Agnello, M. Romano, and A. Cianci, “Quality of sexual life in hyperandrogenic women treated with an oral contraceptive containing chlormadinone acetate,” Journal of Sexual Medicine, vol. 6, no. 12, pp. 3376–3384, 2009.
[20]
G. Arslan, U. Ayranci, A. Unsal, and D. Arslantas, “Prevalence of depression, its correlates among students, and its effect on health-related quality of life in a Turkish university,” Upsala Journal of Medical Sciences, vol. 114, no. 3, pp. 170–177, 2009.
[21]
J. E. Do, S.-M. Cho, S.-I. In, K.-Y. Lim, S. Lee, and E.-S. Lee, “Psychosocial aspects of acne vulgaris: a community-based study with Korean adolescents,” Annals of Dermatology, vol. 21, no. 2, pp. 125–129, 2009.
[22]
E. Mallon, J. N. Newton, A. Klassen, S. L. Stewart-Brown, T. J. Ryan, and A. Y. Finlay, “The quality of life in acne: a comparison with general medical conditions using generic questionnaires,” British Journal of Dermatology, vol. 140, no. 4, pp. 672–676, 1999.
[23]
N. Takahashi, Y. Suzukamo, M. Nakamura et al., “Japanese version of the Dermatology Life Quality Index: validity and reliability in patients with acne,” Health and Quality of Life Outcomes, vol. 4, article 46, 2006.
[24]
R. J. Lasek and M.-M. Chren, “Acne vulgaris and the quality of life of adult dermatology patients,” Archives of Dermatology, vol. 134, no. 4, pp. 454–458, 1998.
[25]
M. Jones-Caballero, M. M. Chren, B. Soler, E. Pedrosa, and P. F. Pe？as, “Quality of life in mild to moderate acne: relationship to clinical severity and factors influencing change with treatment,” Journal of the European Academy of Dermatology and Venereology, vol. 21, no. 2, pp. 219–226, 2007.
[26]
Y. Matsuoka, K. Yoneda, C. Sadahira, J. Katsuura, T. Moriue, and Y. Kubota, “Effects of skin care and makeup under instructions from dermatologists on the quality of life of female patients with acne vulgaris,” Journal of Dermatology, vol. 33, no. 11, pp. 745–752, 2006.
[27]
R. Fried and M. Nighland, “Acne quality of life and patient satisfaction following treatment with tretinoin pump,” Journal of Drugs in Dermatology, vol. 8, no. 12, pp. 1080–1085, 2009.
[28]
B. D？eno, “Assessing quality of life in patients with acne vulgaris: implications for treatment,” American Journal of Clinical Dermatology, vol. 7, no. 2, pp. 99–106, 2006.
[29]
M. Jones-Caballero, E. Pedrosa, and P. F. Pe？as, “Self-reported adherence to treatment and quality of life in mild to moderate acne,” Dermatology, vol. 217, no. 4, pp. 309–314, 2008.
[30]
R. Lott, S. L. Taylor, J. L. O'Neill, D. P. Krowchuk, and S. R. Feldman, “Medication adherence among acne patients: a review,” Journal of Cosmetic Dermatology, vol. 9, no. 2, pp. 160–166, 2010.
[31]
M. Salamon, J. Chodkiewicz, A. Sysa-Jedrzejowska, and A. Wozniacka, “Quality of life in patients with rosacea,” Przegl？d Lekarski, vol. 65, no. 9, pp. 385–389, 2008.
[32]
N. Motamed, A. R. Ayatollahi, N. Zare, and A. Sadeghi-Hassanabadi, “Validity and reliability of the Persian translation of the SF-36 version 2 questionnaire,” Eastern Mediterranean Health Journal, vol. 11, no. 3, pp. 349–357, 2005.
[33]
A. Montazeri, A. Goshtasebi, M. Vahdaninia, and B. Gandek, “The Short Form Health Survey (SF-36): translation and validation study of the Iranian version,” Quality of Life Research, vol. 14, no. 3, pp. 875–882, 2005.
[34]
H. Jafari, S. Lahsaeizadeh, P. Jafari, and M. Karimi, “Quality of life in thalassemia major: reliability and validity of the Persian version of the SF-36 questionnaire,” Journal of Postgraduate Medicine, vol. 54, no. 4, pp. 273–275, 2008.
[35]
J. E. Ware and M. Kosinski, “Interpreting SF-36 summary health measures: a response,” Quality of Life Research, vol. 10, no. 5, pp. 405–413, 2001.
[36]
M. A. Radtke, I. Sch？fer, and M. Augustin, “Pharmacoeconomy in acne—evaluation of benefit and economics,” Journal der Deutschen Dermatologischen Gesellschaft, vol. 8, Suppl 1, pp. S105–S114, 2010.
[37]
Z. Demircay, D. Seckin, A. Senol, and F. Demir, “Patient's perspective: an important issue not to be overlooked in assessing acne severity,” European Journal of Dermatology, vol. 18, no. 2, pp. 181–184, 2008.
[38]
S. Ammad, M. Gonzales, C. Edwards, A. Y. Finlay, and C. Mills, “An assessment of the efficacy of blue light phototherapy in the treatment of acne vulgaris,” Journal of Cosmetic Dermatology, vol. 7, no. 3, pp. 180–188, 2008.
[39]
B. J. Hahm, S. U. Min, M. Y. Yoon et al., “Changes of psychiatric parameters and their relationships by oral isotretinoin in acne patients,” Journal of Dermatology, vol. 36, no. 5, pp. 255–261, 2009.
